Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2.
Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2. J Appl Lab Med. 2021 11 01; 6(6):1561-1570.
-
Petr Jarolim, Ph.D., M.D.
-
Galit Alter, Ph.D.
-
Nicole Tolan, Ph.D.
-
Eric J Nilles, M.D.
-
Elizabeth Wood Karlson, M.D.
-
Peter Henry Schur, M.D.
-
Lindsey Robert Baden, M.D.
-
Daimon Peter Simmons, M.D.
-
David Walt, Ph.D.